Format

Send to

Choose Destination
J Urol. 2014 Feb;191(2):561-3. doi: 10.1016/j.juro.2013.09.037. Epub 2013 Nov 12.

Re: clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies: M. Gelbard, I. Goldstein, W. J. Hellstrom, C. G. McMahon, T. Smith, J. Tursi, N. Jones, G. J. Kaufman and C. C. Carson, III J Urol 2013; 190: 199-207.

Author information

1
Department of Urology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
2
Department of Urology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Electronic address: ravismi2003@yahoo.com.

Comment in

PMID:
24239419
DOI:
10.1016/j.juro.2013.09.037
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center